HOOK HOOKIPA Pharma Inc. revenue, earnings and financials
For the quarter ended March 31, 2025, HOOKIPA Pharma Inc. reported revenue of $2.00M (down 94.5% from a year earlier), net income of −$15.4M and diluted EPS of −$1.23; over the last four quarters revenue was $9.35M and net income −$73.3M; for the fiscal year ended December 2024 revenue was $43.9M, up 118.3% on the year before.
HOOK annual revenue and earnings
- Fiscal year ended Dec 2024: revenue $43.9M, gross profit n/a, operating income −$51.5M, net income −$43.5M (margin -99.0%), EPS −$3.47
- Fiscal year ended Dec 2023: revenue $20.1M, gross profit n/a, operating income −$97.7M, net income −$81.6M (margin -405.3%), EPS −$8.63
- Fiscal year ended Dec 2022: revenue $14.2M, gross profit n/a, operating income −$73.2M, net income −$64.9M (margin -455.6%), EPS −$9.91
- Fiscal year ended Dec 2021: revenue $18.4M, gross profit n/a, operating income −$81.7M, net income −$75.7M (margin -410.2%), EPS −$2.30
HOOK quarterly revenue and earnings
- Quarter ended Mar 31, 2025: revenue $2.00M (down 94.5% year over year), net income −$15.4M, EPS −$1.23
- Quarter ended Dec 31, 2024 (from the annual report): revenue $1.35M (down 81.7% year over year), net income −$24.9M, EPS −$1.99
- Quarter ended Sep 30, 2024: revenue $4.70M (down 31.5% year over year), net income −$13.8M, EPS −$1.10
- Quarter ended Jun 30, 2024: revenue $1.29M (down 51.8% year over year), net income −$19.1M, EPS −$1.52
- Quarter ended Mar 31, 2024: revenue $36.6M (up 1052.4% year over year), net income $14.4M, EPS $1.14
- Quarter ended Dec 31, 2023 (from the annual report): revenue $7.41M (down 5.4% year over year), net income −$24.8M, EPS −$4.45
- Quarter ended Sep 30, 2023: revenue $6.87M (up 207.9% year over year), net income −$19.1M, EPS −$1.73
- Quarter ended Jun 30, 2023: revenue $2.68M (down 2.4% year over year), net income −$18.0M, EPS −$2.18
- Quarter ended Mar 31, 2023: revenue $3.18M (up 119.8% year over year), net income −$19.7M, EPS −$0.27
- Quarter ended Dec 31, 2022 (from the annual report): revenue $7.83M (up 101.0% year over year), net income −$12.3M, EPS −$9.03
- Quarter ended Sep 30, 2022: revenue $2.23M (down 42.4% year over year), net income −$18.3M, EPS −$0.25
- Quarter ended Jun 30, 2022: revenue $2.75M (down 48.9% year over year), net income −$16.4M, EPS −$0.23
- Quarter ended Mar 31, 2022: revenue $1.45M (down 72.7% year over year), net income −$18.0M, EPS −$0.40
- Quarter ended Dec 31, 2021 (from the annual report): revenue $3.90M, net income −$21.2M, EPS −$0.64
- Quarter ended Sep 30, 2021: revenue $3.87M, net income −$20.0M, EPS −$0.61
- Quarter ended Jun 30, 2021: revenue $5.38M, net income −$17.2M, EPS −$0.52
- Quarter ended Mar 31, 2021: revenue $5.30M, net income −$17.2M, EPS −$0.53
HOOK cash flow, buybacks and dividends
- Fiscal year ended Dec 2024: operating cash flow −$77.0M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$57.5M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$20.0M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$66.0M, share buybacks n/a
HOOK balance sheet
- Mar 31, 2025: cash $40.3M, total assets $61.3M, total liabilities $27.2M, shareholders' equity $34.1M
- Dec 31, 2024: cash $39.7M, total assets $82.5M, total liabilities $31.3M, shareholders' equity $51.2M
- Sep 30, 2024: cash $59.8M, total assets $110M, total liabilities $37.9M, shareholders' equity $71.8M
- Jun 30, 2024: cash $77.2M, total assets $125M, total liabilities $39.0M, shareholders' equity $86.1M
- Mar 31, 2024: cash $92.8M, total assets $146M, total liabilities $41.3M, shareholders' equity $105M
- Dec 31, 2023: cash $117M, total assets $161M, total liabilities $71.5M, shareholders' equity $89.9M
- Sep 30, 2023: cash $108M, total assets $164M, total liabilities $69.0M, shareholders' equity $95.1M
- Jun 30, 2023: cash $136M, total assets $191M, total liabilities $78.8M, shareholders' equity $112M
What is HOOK's revenue?
HOOKIPA Pharma Inc. reported $9.35M of revenue over its last four quarters, through March 31, 2025.
Is HOOK profitable?
No. HOOKIPA Pharma Inc. lost $73.3M over the last four quarters.
What is HOOK's EPS?
Diluted earnings per share over the last four quarters were −$5.84; −$1.23 in the latest quarter.